TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation

Table 2 KEGG Pathways enriched in high-risk and low-risk groups using GSEA

NAME	SIZE	ES	NES	NOM p-val	FDR q-val	FWER p-val	Rank at max	Leading edge
KEGG_HSA04152_AMPK_SIGNALING_PATHWAY	95	0.2476375	1.2687452	0	0.4344668	1	1244	tags = 14%, list = 10%, signal = 15%

ISSN: 1756-9966